LudicrousSpeed said:
They have been talking it up as the next big thing in MP. Of course, that has literally nothing to do with anything high sales can accomplish. If anything, the delay into this time of year should show you the publisher is not expecting it to light up sales charts. So Bloodborne will all the hype and expectations can sell as little as 1.5 million and still not be a bomb, what does Evolve have to sell? Just curious where the different standards lie. |
The bolded makes no sense at all.
Also I should note that I expect Bloodborne to sell more in 2 million range, maybe more, but to note the difference:
Japanese games are generally cheaper to make than games from the US, most likely due to japanese devs just making less money.
Also Evolve was longer in development than Bloodborne, as far as I know (someone might have different info) development on Bloodborne didn't start until the Artorias DLC for Dark Souls was finished, so summer 2012. Evolve was already in development in May 2011 (and I'm not saying it started in 2011), though I guess we can break down the cost until the end of 2012 to the 10.8 million that Take 2 paid for Evolve's publishing rights. Still it's those 10.8 million plus another 2 years in development, plus marketing... yeah I'm pretty sure that Evolve is significantly more expensive than Bloodborne.







